Entry into Peripheral Stent Market
11 Maggio 2010 - 8:00AM
UK Regulatory
TIDMCTN
RNS Number : 6620L
ClearStream Technologies Group PLC
11 May 2010
For Immediate Release
11 May 2010
ClearStream Technologies Group plc ("ClearStream Technologies")
Entry into Peripheral Stent Market
New self-expanding stent to be marketed under the "SilkenFlex" brand name
ClearStream Technologies is pleased to announce that it has signed a 5-year
contract with Advanced Vision Medical Technologies GmbH, based in Switzerland
for the purchase of a range of self-expanding stents for use in the peripheral
vascular arteries above and below the knee. The stents will be distributed
globally by ClearStream, subject to obtaining regulatory approval in specific
markets, through its network of international distributors under the brand name
"SilkenFlex" and are expected to be released to the market in the final quarter
of this calendar year.
Frost & Sullivan, Inc*. the internationally renowned US based management
consulting and technical research specialists estimate that stents are used in
35 per cent of all peripheral vascular procedures. With annual growth rates
across Europe for these procedures running at between 14 and 17per cent this
clearly remains an attractive market for ClearStream and a key part of the
Company's future strategy.*
Commenting on the new contract, Andrew Jones, CEO of ClearStream, said: "the
SilkenFlex is a very exciting and important addition to ClearStream's product
portfolio for the treatment of peripheral vascular disease (PVD). This new range
of self-expanding stents will enable us to offer an ever broader range of
treatment options to our customers. We have been particularly impressed with its
design and construction, which utilises a low injury stent design consistent
with our own stent design philosophy yet novel within the peripheral arena. The
SilkenFlex will be supplied in a range of sizes compatible with and
complementary to ClearStream's unique, market-leading portfolio of peripheral
balloon products. We believe its introduction will further drive ClearStream's
growth in the expanding market for the treatment of PVD in the coming years."
*
http://www.slideshare.net/FrostandSullivan/understanding-the-peripheral-vascula
-toolkit-an-analysis-of-trends-strategies-and-opportunities-in-the-us-periphera
-intervention-market
-ends-
For further information:
+-------------------------------+----+------------------------+
| ClearStream Technologies | | Tel: + 353 (0) 53 923 |
| Group plc | | 7111 |
+-------------------------------+----+------------------------+
| Andrew Jones, CEO | | |
| | | |
+-------------------------------+----+------------------------+
| Winningtons Financial | | Tel: + 44 (0) 117 985 |
| | | 8989 |
+-------------------------------+----+------------------------+
| Paul Vann | | |
| | | |
+-------------------------------+----+------------------------+
| FinnCap | | Tel: + 44 (0) 20 7600 |
| | | 1658 |
+-------------------------------+----+------------------------+
| Marc Young | | |
+-------------------------------+----+------------------------+
Charlotte Stranner
About ClearStream Technologies Group plc:
ClearStream Technologies Group plc, based in Enniscorthy, Co. Wexford, Ireland,
is an innovative maker of medical devices used in interventional procedures,
including catheters and stents. Its products are sold under ClearStream's own
brands and are also supplied to Original Equipment Manufacturers.
The Company is listed on the AIM market of the London Stock Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFLRERIILII
Grafico Azioni Clearstream (LSE:CTN)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Clearstream (LSE:CTN)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Clearstream (Borsa di Londra): 0 articoli recenti
Più Clearstream Articoli Notizie